迫切需要新的NTM治疗治疗方案。 对临床试验中所列出的正在进行的新型NTM治疗临床试验，使用术语“Mycobacterium avium”、 “Mycobacterium abscessus”、“Mycobacterium ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that ...

Mycobacterium avium complex (MAC) is group of organisms causing a bacterial infection that leads to lung disease. MAC is ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

While unvaccinated macaque monkeys exhibited signs of severe lung inflammation and disease following the Mycobacterium  tuberculosis infection (warm colors indicate inflammation and disease, bottom ...

The new WHO-approved MDR-TB treatment BPaL(M) offers hope for tuberculosis patients but is already encountering resistance. A ...

Engineered kill-switch-encoding Mycobacterium tuberculosis infects, elicits immune responses and is cleared from immunocompetent and immunocompromised mice, providing a model of controlled ...

LHNVD-303 is designed to prevent bacterial infections, and clear associated toxins, including those related to Mycobacterium tuberculosis, using a targeted combination of lipoteichoic acid ...